- Home
- ARVN vs RBBN Comparison
ARVN vs RBBN Comparison
Compare ARVN & RBBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- RBBN
- Stock Information
- Founded
- ARVN 2015
- RBBN 1997
- Country
- ARVN United States
- RBBN United States
- Employees
- ARVN 430
- RBBN N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- RBBN EDP Services
- Sector
- ARVN Health Care
- RBBN Technology
- Exchange
- ARVN Nasdaq
- RBBN Nasdaq
- Market Cap
- ARVN 676.2M
- RBBN 671.1M
- IPO Year
- ARVN 2018
- RBBN 2000
- Fundamental
- Price
- ARVN $9.45
- RBBN $3.50
- Analyst Decision
- ARVN Buy
- RBBN Strong Buy
- Analyst Count
- ARVN 23
- RBBN 4
- Target Price
- ARVN $17.61
- RBBN $6.00
- AVG Volume (30 Days)
- ARVN 2.6M
- RBBN 716.2K
- Earning Date
- ARVN 11-04-2025
- RBBN 10-22-2025
- Dividend Yield
- ARVN N/A
- RBBN N/A
- EPS Growth
- ARVN N/A
- RBBN N/A
- EPS
- ARVN N/A
- RBBN N/A
- Revenue
- ARVN $372,800,000.00
- RBBN $868,592,000.00
- Revenue This Year
- ARVN $1.01
- RBBN $7.26
- Revenue Next Year
- ARVN N/A
- RBBN $5.52
- P/E Ratio
- ARVN N/A
- RBBN N/A
- Revenue Growth
- ARVN 299.57
- RBBN 7.38
- 52 Week Low
- ARVN $5.90
- RBBN $3.01
- 52 Week High
- ARVN $29.61
- RBBN $5.38
- Technical
- Relative Strength Index (RSI)
- ARVN 57.54
- RBBN 38.98
- Support Level
- ARVN $9.01
- RBBN $3.18
- Resistance Level
- ARVN $9.55
- RBBN $3.59
- Average True Range (ATR)
- ARVN 0.49
- RBBN 0.13
- MACD
- ARVN -0.10
- RBBN -0.03
- Stochastic Oscillator
- ARVN 44.37
- RBBN 35.16
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About RBBN Ribbon Communications Inc.
Ribbon Communications Inc provides network solutions to service providers and enterprises. The company enables service providers and enterprises to modernize their communications networks and provide secure real-time communications solutions to their customers and employees. The company has two separate lines of business; the Cloud and Edge segment, and the IP Optical Networks segment. The majority of the revenue for the company is generated from its Cloud and Edge segment that provides secure and reliable software and hardware products, solutions, and services for VoIP communications, Voice Over LTE among others to service providers and enterprise customers. The company generates majority of its revenue from United States.